Prucalopride for constipation.

Michael Camilleri, Annemie Deiteren

Journal: Expert opinion on pharmacotherapy 2010;11(3):451-61

PMID: 20102308

Abstract

IMPORTANCE OF THE FIELD

Chronic constipation has a high prevalence, and current medical and pharmacological therapies do not restore normal bowel function in all patients.

AREAS COVERED IN THE REVIEW

A PubMed search (1965 - 2009) using the following terms alone or in combination: prucalopride, 5-HT(4), R093877, safety, toxicity, pharmacokinetics, pharmacodynamics, transit, cardiac, hERG, arrhythmia, potassium current, elderly.

WHAT THE READER WILL GAIN

Understanding of the mechanisms of action, safety, efficacy and indications for prucalopride in patients with chronic constipation.

TAKE HOME MESSAGE

Prucalopride is an efficacious and generally safe, new therapeutic option in the management of chronic constipation.

Address: Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), College of Medicine, Mayo Clinic, Charlton 8-110, 200 First St S.W., Rochester, MN 55905, USA. [email protected]

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.